MHC-linked type 1 diabetes genes in NOD mice
MHC-linked type 1 diabetes genes in NOD mice
批准号:
22500399
负责人:
HATTORI Masakazu
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
1型糖尿病是一种人类和NOD小鼠的多基因自身免疫性疾病。MHC区域的基因在决定1型糖尿病的易感性或抵抗力方面是最重要的。将NOD MHC类IK区(同源重组)替换为R209 MHC类IK区,可预防MHC内重组NOD小鼠发生糖尿病和胰腺炎。类似地,用R209的NODA、E和D区域替换可以预防糖尿病和胰岛素炎的发生。我们在距LMP2热点7.4Mbp以内的区域建立了6个r209/r209纯合片段的同源系,在距着丝粒23Mbp以内的区域建立了两个r209/r209纯合片段的同源系。我们的观察表明,在LMP2基因着丝粒的33.9Mbp区域,除了MHC II A外,还有4个MHC连锁的1型糖尿病基因,分别是Idd1a、Idd1b、Idd1c和Idd1d。我们的研究旨在识别这四个基因,并研究它们在1型糖尿病发生发展中的作用。
英文摘要
Type 1 diabetes is a polygenic autoimmune disease in man and the NOD mouse. The genes in the MHC region are the most important in determining susceptibility or resistance to type 1 diabetes. Replacement of (homologous recombination) of the NOD MHC class IK region with the R209 MHC class IK region prevented the development of diabetes and insulitis in the intra-MHC recombinant NOD mice. Similarly the replacement of the region of the NOD A, E and D with that of the R209 prevented the development of diabetes and insulitis. We have established six congenic lines with a homozygous segment of r209/r209 in the region of within 7.4 Mbp centromeric to the Lmp2-hotspot, and two congeniclines with homozygous segment of r209/r209 in the region of within 23 Mbp from the centromere. Our observation suggests that in addition to the MHC class II A there are four more MHC-linked type 1 diabetogenic genes in the 33.9 Mbp region centromeric to the Lmp2 gene, Idd1a, Idd1b, Idd1c and Idd1d. Our study aims to identify the four genes and examine their functions in the development of type 1 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The 6th USA-Japan Meeting on Diabetes at Kyoto Medical Center, March 17-18, 2012
第六届美日糖尿病会议于 2012 年 3 月 17-18 日在京都医学中心举行
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities.
具有抗糖尿病和抗代谢综合征活性的金属蒜氨酸复合物。
DOI:
--
发表时间:
2010
期刊:
Metallomics (The Royal Society of Chemistry)
影响因子:
--
作者:
[Sakurai H, Katoh A, Kiss T, Jakusch T, Hattori M.]
通讯作者:
Hattori M.
生活習慣病に対する新しい治療 DPP-IV阻害薬:2型糖尿病治療におけるインクレチン分解抑制の重要性
生活方式相关疾病新疗法DPP-IV抑制剂:抑制肠促胰素降解在治疗2型糖尿病中的重要性
DOI:
--
发表时间:
2010
期刊:
Journal of Integrated Medicine (JIM)
影响因子:
--
作者:
[服部正和, 知念良直, 中川嘉苗, 島津章, 桜井弘, William Sullivan]
通讯作者:
William Sullivan
生活習慣に対する新しい治療、DPP-IV阻害薬 : 2型糖尿病治療におけるインクレチン分解抑制の重要性
DPP-IV抑制剂,治疗生活习惯的新疗法:抑制肠促胰素降解在治疗2型糖尿病中的重要性
DOI:
--
发表时间:
2010
期刊:
Journal of Integrated Medicine (JIM).
影响因子:
--
作者:
[服部正和, 知念良直, 中川嘉苗, 島津章, 桜井弘, William Sullivan.]
通讯作者:
William Sullivan.
DOI:
10.1093/intimm/dxp127
发表时间:
2010-03-01
期刊:
INTERNATIONAL IMMUNOLOGY
影响因子:
4.4
作者:
[Brims, Daniel R., Qian, Jie, DiLorenzo, Teresa P.]
通讯作者:
DiLorenzo, Teresa P.
共 8 条
Study on the mechanism(s) of immunosenescence and its application for vaccine development.
-
批准号:26450443
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2014
-
负责人:HATTORI Masakazu
-
依托单位:
A new model mice for human chronic myelogenous leukemia by the disruption of SPA-1 gene.
-
批准号:15590337
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:HATTORI Masakazu
-
依托单位:
Regulation of T-cell and antigen-presenting cell interactions by Rapl.
-
批准号:12670300
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2000
-
负责人:HATTORI Masakazu
-
依托单位:
Essential role of transcriptional regulator Hesl in the early development of T cells.
-
批准号:10670300
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HATTORI Masakazu
-
依托单位:
Cell cycle regulation of a lympho-hematopoietic specific Rap1GTPase-activating protein, Spa-1 in lymphocyres.
-
批准号:07670367
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:HATTORI Masakazu
-
依托单位:
Analysis of a lympho-hematopoietic specific nuclear protein with homology to RaplGAP
-
批准号:05670300
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:HATTORI Masakazu
-
依托单位:
海外基金